Institutional Ownership Eagle Pharmaceuticals, Inc. (EGRX)
This table provides information about the institutional ownership of Eagle Pharmaceuticals, Inc. (EGRX). We have compiled data on the 7 institutions that hold shares in the stock, with a total of 431,128 shares, which have been reported (via 13F filing form) to have a value of $711,000.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
352,762
shares
|
$705,524
0.0% of portfolio
|
Q2 2024
Reduced 60.71%
|
|
|
Ajo Vista, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
56,438
shares
|
$112,876
0.92% of portfolio
|
Q3 2024
Added 402.48%
|
|
|
Stanley Laman Group, Ltd.
Berwyn, PA |
Apr 16, 2025 Q1 2025 |
12,000
shares
|
$24,000
0.0% of portfolio
|
Q2 2022
Reduced 50.0%
|
|
|
Hightower 6 M Holding, LLC
|
Oct 25, 2022 Q3 2022 |
8,862
shares
|
$17,724
0.02% of portfolio
|
Q3 2022
Reduced 2.78%
|
|
|
Wipfli Financial Advisors Llc,
|
Oct 26, 2022 Q3 2022 |
661
shares
|
$1,322
0.0% of portfolio
|
Q3 2022
New holding
|
|
|
Archer Investment Corp
|
May 05, 2025 Q1 2025 |
350
shares
|
$700
0.0% of portfolio
|
Q3 2023
Added 19.45%
|
|
|
Private Capital Group, LLC
|
Jul 28, 2022 Q2 2022 |
55
shares
|
$110
0.0% of portfolio
|
Q1 2022
Reduced 23.61%
|